Treatment of infertility with somatotrophin releasing factor

Details Treatment of infertility with somatotrophin releasing factor Treatment of infertility with somatotrophin releasing factor

1988-07-08

1991-05-21

Moezie, F. T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 21, A61K 3724, A61K 3736

Patent

active

050175572

ABSTRACT:
The use of somatotrophin releasing factor (GRF) is disclosed for the treatment of infertility in females and males. Also disclosed for such treatment is the use of somatotrophin releasing factor along with gonadotrophins, particularly follicle stimulating hormone (FSH) or preparations containing FSH. Pharmaceutical preparations containing somatotrophin releasing factor, including preparations containing both somatotrophin releasing factor and follicle stimulating hormone, are also disclosed.

REFERENCES:
patent: 4910215 (1990-03-01), Muller
Stedman's Medical Dictionary, 24th ed., Williams and Wilkins, Baltimore, 1982, p. 601.
Arce, Nemoendocrinology, 52/51/90:119, 1990, Poster 3.50 of 2nd Int'l Cong. of Neuroendocrinology held Jun. 24-29, 1990.
Valcari, Clin. Endocrinol., 29:309, 1988.

Affiliated with

Also associated with

Rating

Treatment of infertility with somatotrophin releasing factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of infertility with somatotrophin releasing factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of infertility with somatotrophin releasing factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-238486